{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:05:01Z","timestamp":1787065501349,"version":"build-2736575974"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jaad.2019.11.020","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T20:03:44Z","timestamp":1573848224000},"page":"228-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["When the treatment is the culprit: Prevalence of allergens in prescription topical steroids and immunomodulators"],"prefix":"10.1016","volume":"83","author":[{"given":"Jennifer M.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo J.","family":"Reeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2019.11.020_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaad.2018.07.017","article-title":"Allergic contact dermatitis to personal care products and topical medications in adults with atopic dermatitis","volume":"79","author":"Rastogi","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.11.020_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/DER.0000000000000488","article-title":"Allergic contact dermatitis to crisaborole","volume":"30","author":"Kimyon","year":"2019","journal-title":"Dermatitis"},{"issue":"6","key":"10.1016\/j.jaad.2019.11.020_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/DER.0000000000000417","article-title":"North American Contact Dermatitis Group patch test results: 2015-2016","volume":"29","author":"DeKoven","year":"2018","journal-title":"Dermatitis"},{"issue":"5 Suppl","key":"10.1016\/j.jaad.2019.11.020_bib4","doi-asserted-by":"crossref","first-page":"73S","DOI":"10.1177\/1091581811412618","article-title":"Annual review of cosmetic ingredient safety assessments: 2007-2010","volume":"30","author":"Andersen","year":"2011","journal-title":"Int J Toxicol"},{"issue":"2","key":"10.1016\/j.jaad.2019.11.020_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/DER.0000000000000031","article-title":"Contact sensitivity to preservatives in Singapore: frequency of sensitization to 11 common preservatives 2006-2011","volume":"25","author":"Cheng","year":"2014","journal-title":"Dermatitis"},{"issue":"4","key":"10.1016\/j.jaad.2019.11.020_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cod.12536","article-title":"Sorbitan sesquioleate; a rare cause of contact allergy in consecutively patch tested dermatitis patients","volume":"74","author":"Bennike","year":"2016","journal-title":"Contact Derm"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221933110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221933110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:54:08Z","timestamp":1759272848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221933110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S019096221933110X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.11.020","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When the treatment is the culprit: Prevalence of allergens in prescription topical steroids and immunomodulators","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}